Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes

British Journal of Cancer

Volumn 83, Issue 10, 2000, Pages 1387-1393

  Baumann, P ^a   Zigrino, P ^a   Mauch, C ^a   Breitkreutz, D ^b   Nischt, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Activation; Cell matrix interactions; HaCaT ras; Keratinocytes; Type IV collagenases

Indexed keywords

COLLAGEN TYPE 1; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; PROGELATINASE A; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TUMOR GROWTH;

EID: 0033752213     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1454     Document Type: Article

References (44)

1. Collagen-induced activation of the Mr 72,000 type IV gelatinase in normal and malignant fibroblastoid cells
2. Matrix metalloproteinases: A review
3. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
4. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy
5. Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants
6. Independent expression and cellular processing of M(r) 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
7. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
8. The TIMP-2 membrane type metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A
9. Membrane-type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain
10. Regulation of the C/EBP related gene gadd153 by glucose deprivation
11. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
12. Implication of collagen type I-induced membrane-type 1 matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinomas
13. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1 independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
14. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinase MT1-MMP and MMP-2 in microvascular endothelial cells
15. Secretion of metalloproteinases by stimulated capillary endothelial cells
16. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activation on the cell surface
17. Soluble latent membrane-type 1 matrix metalloprotease secreted by mesangial cells is activated by urokinase
18. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cells
19. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinomas. A clinicopathologic study
20. Proteolytic processing of membrane-type 1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
21. Inhibition of matrix metalloproteinase-2 maturation and HT 1080 invasiveness by a synthetic furin inhibitor
22. Regulation of collagen synthesis in fibroblast within a three-dimensional collagen gel
23. Differential expression of matrix metalloproteinases in activated c-ras(Ha)-transfected immortalized human keratinocytes
24. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
25. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, head and neck carcinomas
26. Proteolytic activation of the precursor of membrane-type 1 matrix metalloproteinase by human plasmin
27. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
28. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
29. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma
30. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
31. A matrix metalloproteinase expressed on the surface of invasive tumor cells
32. Cell surface binding and activation of gelatinase A induced by expression of membrane-type matrix metalloproteinase (MT1-MMP)
33. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction
34. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
35. Tumor cell interaction with the extracellular matrix during invasion and metastasis
36. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
37. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
38. Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family
39. Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts
40. Expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay
41. cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane domain
42. The soluble catalytic domain of type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation
43. Molecular regulation of cellular invasion - Role of gelatinase A and TIMP-2
44. Tissue inhibitor of metalloproteinase-(TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)